EDAP vs. ZYXI, AXGN, HYPR, VRAY, FONR, BLFS, OM, RCEL, VNDA, and VOR
Should you be buying Edap Tms stock or one of its competitors? The main competitors of Edap Tms include Zynex (ZYXI), AxoGen (AXGN), Hyperfine (HYPR), ViewRay (VRAY), FONAR (FONR), BioLife Solutions (BLFS), Outset Medical (OM), AVITA Medical (RCEL), Vanda Pharmaceuticals (VNDA), and Vor Biopharma (VOR). These companies are all part of the "medical" sector.
Edap Tms vs.
Edap Tms (NASDAQ:EDAP) and Zynex (NASDAQ:ZYXI) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, valuation, institutional ownership, risk, media sentiment, community ranking, earnings, dividends and profitability.
Edap Tms has a beta of 1.25, suggesting that its share price is 25% more volatile than the S&P 500. Comparatively, Zynex has a beta of 0.59, suggesting that its share price is 41% less volatile than the S&P 500.
Edap Tms currently has a consensus price target of $13.75, suggesting a potential upside of 52.78%. Zynex has a consensus price target of $19.63, suggesting a potential upside of 125.57%. Given Zynex's higher probable upside, analysts plainly believe Zynex is more favorable than Edap Tms.
In the previous week, Edap Tms' average media sentiment score of 0.00 equaled Zynex's average media sentiment score.
Zynex has higher revenue and earnings than Edap Tms. Edap Tms is trading at a lower price-to-earnings ratio than Zynex, indicating that it is currently the more affordable of the two stocks.
48.8% of Edap Tms shares are owned by institutional investors. Comparatively, 28.6% of Zynex shares are owned by institutional investors. 0.2% of Edap Tms shares are owned by insiders. Comparatively, 46.6% of Zynex shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
Zynex has a net margin of 10.19% compared to Edap Tms' net margin of -19.22%. Zynex's return on equity of 26.02% beat Edap Tms' return on equity.
Edap Tms received 323 more outperform votes than Zynex when rated by MarketBeat users. Likewise, 63.50% of users gave Edap Tms an outperform vote while only 46.15% of users gave Zynex an outperform vote.
Summary
Zynex beats Edap Tms on 10 of the 15 factors compared between the two stocks.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding EDAP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Edap Tms Competitors List
Related Companies and Tools